MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
| hmdb:HMDB0056404 KKWXRBCFUWCTKE-VYZLELIXSA-N | CL(16:0/16:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (2S)-3-{[(2R)-2,3-bis(hexadecanoyloxy)propoxy(hydroxy)phosphoryl]oxy}-2-hydroxypropoxy((2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3-(octadecanoyloxy)propoxy)phosphinic acid 1'-[1,2-Dihexadecanoyl-rac-glycero-3-phospho],3'-[1,2-dioctadecanoyl-rac-glycero-3-phospho]-glycerol 1'-[1,2-Dipalmitoyl-rac-glycero-3-phospho],3'-[1,2-distearoyl-rac-glycero-3-phospho]-glycerol CL(1'-[16:0/16:0],3'-[18:0/18:0]) CL(16:0/16:0/18:0/18:0) CL(68:0) Cardiolipin(16:0/16:0/18:0/18:0) Cardiolipin(68:0) [(2S)-3-({[(2R)-2,3-bis(hexadecanoyloxy)propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy][(2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3-(octadecanoyloxy)propoxy]phosphinic acid |
SLM:000509403 slm:000509403 KKWXRBCFUWCTKE-TWQBDFPHSA-L | Cardiolipin (16:0/16:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z)) 1'-[1,2-di-hexadecanoyl-sn-glycero-3-phospho],3'-[1-octadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phospho]-glycerol CL (16:0/16:0/18:0/22:5(4Z,7Z,10Z,13Z,16Z)) |
hmdb:HMDB56404 | secondary/obsolete/fantasy identifier |